Stonington Superintendent of Schools Van Riley has finalized a plan that will have all Stonington students returning to four days of in-person learning by April 5.
Riley created the plan over the weekend with school administrators after parents and school board members again pressed him last week to bring students back to in-person learning faster than what he has proposed in several earlier plans. They pointed to other area school districts that had plans to bring students back faster.
The plan now calls for grades 2 and 3 to return this coming Monday, with grades 4, 5, 7 and 10 returning on March 29 and grades 8, 11 and 12 on April 5. Students in kindergarten and grades 1, 6 and 9 already returned this past Monday. The school system will have its spring break the week of April 12.
Mystic A local grassroots group, whose 117 members meet quarterly to pool their $100 contributions, has now awarded almost $200,000 to area organizations.
Power of Together 2, which formed in 2016 as an offshoot of a similar East-Lyme based group, made its latest donation $10,700 to FRESH New London last Friday.
Gae Melford, one of the group s organizers and co-founders, said that while people may donate $50 or $100 on their own to a local organization, they can have a larger impact if they pool their donations. It s exciting that you can raise $11,000 in an hour, she said, referring to the length of the group s quarterly meetings, which have been held virtually since last spring.
Benefits outweigh the risks of AstraZeneca COVID shot as review continues - WHO
A vial with the AstraZeneca s coronavirus disease (COVID-19) vaccine is pictured in Berlin, Germany, March 16, 2021. REUTERS/Hannibal Hanschke reuters tickers
This content was published on March 17, 2021 - 18:56
March 17, 2021 - 18:56
By Stephanie Nebehay
GENEVA (Reuters) - A World Health Organization (WHO) vaccine safety panel said on Wednesday that it considers that the benefits of the AstraZeneca COVID-19 vaccine outweigh its risks and recommends that vaccinations continue.
The WHO listed AstraZeneca and Oxford University s vaccine for emergency use last month, widening access to the relatively inexpensive shot in the developing world.